# Investigation of the Effect of the Atherogenic Index on the Therapeutic Response to Tadalafil in Patients With Vascular Erectile Dysfunction

> **NCT07479901** · — · ACTIVE_NOT_RECRUITING · sponsor: **Taksim Egitim ve Arastirma Hastanesi** · enrollment: 132 (estimated)

## Conditions studied

- Erectile Dysfunction Vascular Erectile Dysfunction Atherogenic Dyslipidemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07479901
- **Lead sponsor:** Taksim Egitim ve Arastirma Hastanesi
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-12
- **Primary completion:** 2026-03-21
- **Final completion:** 2026-04-20
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07479901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07479901, "Investigation of the Effect of the Atherogenic Index on the Therapeutic Response to Tadalafil in Patients With Vascular Erectile Dysfunction". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07479901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*